Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $12.6 Million - $14.3 Million
66,000 Added 227.59%
95,000 $20.2 Million
Q2 2023

Jul 20, 2023

BUY
$187.64 - $206.25 $4.13 Million - $4.54 Million
22,000 Added 314.29%
29,000 $5.58 Million
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $893,130 - $1.42 Million
7,000 New
7,000 $1.42 Million
Q2 2022

Aug 15, 2022

BUY
$108.81 - $179.33 $217,620 - $358,660
2,000 New
2,000 $354,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Harvest Management LLC Portfolio

Follow Harvest Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Management LLC with notifications on news.